MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.310
-0.090 (-6.43%)
Sep 18, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $79.68 million as of September 18, 2026. Its market cap has increased by 56.82% in one year.
Market Cap
79.68M
Enterprise Value
52.09M
1-Year Change
56.82%
Ranking
Category
Stock Price
$1.31
ChartMarket Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $79.68M, an increase of 55.93%. That is a compound annual growth rate of 11.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 79.68M | 36.10% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rallybio | 91.13M |
| ImmuCell | 90.64M |
| Pelthos Therapeutics | 85.68M |
| NeOnc Technologies Holdings | 84.76M |
| OS Therapies | 84.41M |
| Fortress Biotech | 83.71M |
| Aldeyra Therapeutics | 83.25M |
| Connect Biopharma Holdings | 81.24M |